Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients
Date
2012
ISBN
Journal Title
Journal ISSN
Volume Title
Resource Type
Article
Publisher
Asian Pacific Organization for Cancer Prevention
Journal Title
Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients
Recommended by
Abstract
Hepatocellular carcinoma (HCC), the most common primary hepatic tumor, is highly prevalent in the Asia-Pacific region, including Thailand. Many genetic and epigenetic alterations in HCC have been elucidated. The aim of this study was to determine whether aberrant methylation of the suppressor of cytokine signaling 1 gene (SOCS1) occurs in HCCs. Methylation specific-PCR assays were performed to identify the methylation status of SOCS1 in 29 tumors and their corresponding normal liver tissues. An abnormal methylation status was detected in 17 (59%), with a higher prevalence of aberrant SOCS1 methylation significantly correlating with HCC treated without chemotherapy (OR=0.04, 95%CI=0.01-0.31; P=0.001). This study suggests that epigenetic aberrant SOCS1 methylation may be a predictive marker for HCC patients.
Description
Citation
Asian Pacific Journal of Cancer Prevention